14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.95 Wednesday, 24th Apr 2024 IONS stock ended at $42.45. This is 1.46% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.72% from a day low at $41.59 to a day high of $42.72.
90 days $40.39 $52.49
52 weeks $34.32 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Apr 24, 2024 $41.97 $42.72 $41.59 $42.45 697 642
Apr 23, 2024 $41.28 $42.25 $40.91 $41.84 614 603
Apr 22, 2024 $40.84 $41.83 $40.58 $41.07 653 449
Apr 19, 2024 $40.88 $41.16 $40.39 $40.68 781 845
Apr 18, 2024 $41.00 $41.53 $40.77 $40.81 857 705
Apr 17, 2024 $41.37 $41.60 $40.76 $40.91 1 083 335
Apr 16, 2024 $41.55 $42.01 $41.47 $41.54 1 017 089
Apr 15, 2024 $41.73 $42.05 $41.26 $41.55 712 377
Apr 12, 2024 $42.35 $42.55 $41.47 $41.74 815 322
Apr 11, 2024 $43.10 $43.30 $42.07 $42.50 818 784
Apr 10, 2024 $43.29 $43.31 $42.48 $42.94 825 854
Apr 09, 2024 $42.69 $43.04 $42.50 $42.83 778 257
Apr 08, 2024 $43.44 $43.44 $42.21 $42.24 716 971
Apr 05, 2024 $42.63 $43.38 $42.21 $43.22 566 920
Apr 04, 2024 $43.96 $44.07 $42.81 $42.83 899 377
Apr 03, 2024 $42.73 $43.83 $42.68 $43.78 969 002
Apr 02, 2024 $43.51 $43.69 $42.64 $43.00 885 660
Apr 01, 2024 $43.31 $44.08 $42.88 $43.94 687 393
Mar 28, 2024 $44.95 $44.95 $43.32 $43.35 1 904 913
Mar 27, 2024 $44.56 $44.85 $43.83 $44.66 849 705
Mar 26, 2024 $44.35 $44.75 $43.59 $44.11 882 535
Mar 25, 2024 $42.66 $43.99 $42.66 $43.91 846 101
Mar 22, 2024 $42.56 $42.93 $42.33 $42.72 752 488
Mar 21, 2024 $43.00 $43.97 $42.64 $42.75 642 602
Mar 20, 2024 $41.99 $42.80 $41.60 $42.78 539 753
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT